{"disease":{"id":"alzheimer-s","name":"alzheimer s"},"drugs":{"marketed":[{"drug_id":"donepezil","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aricept","generic_name":"DONEPEZIL","company_name":"Eisai","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Cholinesterase Inhibitor","quality_score":75,"revenue":"800","mechanism":"Aricept works by blocking the enzyme that breaks down a key neurotransmitter in the brain, acetylcholine."},{"drug_id":"donepezil","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aricept","generic_name":"DONEPEZIL","company_name":"Eisai","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Cholinesterase Inhibitor","quality_score":75,"revenue":"800","mechanism":"Aricept works by blocking the enzyme that breaks down a key neurotransmitter in the brain, acetylcholine."},{"drug_id":"lecanemab","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Leqembi","generic_name":"LECANEMAB","company_name":"Eisai","drug_phase":"marketed","molecular_target":"Amyloid beta A4 protein","drug_class":"Amyloid Beta-directed Antibody [EPC]","quality_score":10,"revenue":"500","mechanism":"Leqembi works by binding to and removing amyloid beta A4 protein from the brain, which is thought to contribute to the progression of Alzheimer's disease."},{"drug_id":"ipidacrine","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amiridine","generic_name":"IPIDACRINE","company_name":"","drug_phase":"phase_2","molecular_target":"Acetylcholinesterase","drug_class":"ipidacrine","quality_score":28,"revenue":null,"mechanism":"Amiridine works by inhibiting the enzyme Acetylcholinesterase, which breaks down the neurotransmitter acetylcholine."},{"drug_id":"florbetaben","indication_name":"Alzheimer’s disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neuraceq","generic_name":"FLORBETABEN","company_name":"Life Molecular","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":39,"revenue":null,"mechanism":""},{"drug_id":"florbetaben","indication_name":"Alzheimer’s disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neuraceq","generic_name":"FLORBETABEN","company_name":"Life Molecular","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":39,"revenue":null,"mechanism":""},{"drug_id":"galantamine","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Razadyne","generic_name":"GALANTAMINE","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Inhibitor","quality_score":62,"revenue":null,"mechanism":"Razadyne works by blocking the enzyme that breaks down acetylcholine, allowing more of this neurotransmitter to be available in the brain."},{"drug_id":"benzgalantamine","indication_name":"mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zunveyl","generic_name":"BENZGALANTAMINE","company_name":"Alpha Cognition","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":56,"revenue":null,"mechanism":"Zunveyl works by enhancing communication between brain cells, specifically by stimulating cholinergic receptors."},{"drug_id":"flutemetamol","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vizamyl","generic_name":"FLUTEMETAMOL","company_name":"Ge Healthcare","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":50,"revenue":null,"mechanism":"Vizamyl works by binding to amyloid plaques in the brain, allowing for visualization through positron emission tomography (PET) imaging."},{"drug_id":"flutemetamol","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vizamyl","generic_name":"FLUTEMETAMOL","company_name":"Ge Healthcare","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":50,"revenue":null,"mechanism":"Vizamyl works by binding to amyloid plaques in the brain, allowing for visualization through positron emission tomography (PET) imaging."},{"drug_id":"donepezil-aricept","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Donepezil (Aricept)","company_name":"University of Virginia","drug_phase":"marketed","molecular_target":"Beta-secretase 1, Multidrug resistance protein 1, Acetylcholine receptor subunit epsilon","drug_class":"Acetylcholinesterase Inhibitor","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"donepezil-aricept","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Donepezil (Aricept)","company_name":"University of Virginia","drug_phase":"marketed","molecular_target":"Beta-secretase 1, Multidrug resistance protein 1, Acetylcholine receptor subunit epsilon","drug_class":"Acetylcholinesterase Inhibitor","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"exelon","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Exelon","company_name":"US Department of Veterans Affairs","drug_phase":"marketed","molecular_target":"Acetylcholinesterase, Cholinesterase, Acetylcholine receptor subunit epsilon","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"rivastigmine","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Exelon","generic_name":"rivastigmine","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Acetylcholinesterase, Cholinesterase, Acetylcholine receptor subunit epsilon","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"aducanumab","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aduhelm","generic_name":"ADUCANUMAB","company_name":"Biogen","drug_phase":"marketed","molecular_target":"Amyloid beta A4 protein","drug_class":"Amyloid Beta-directed Antibody","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"aricept","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aricept","company_name":"Eisai Korea Inc.","drug_phase":"marketed","molecular_target":"Beta-secretase 1, Multidrug resistance protein 1, Acetylcholine receptor subunit epsilon","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"aricept","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aricept","company_name":"Eisai Korea Inc.","drug_phase":"marketed","molecular_target":"Beta-secretase 1, Multidrug resistance protein 1, Acetylcholine receptor subunit epsilon","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"namenda","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Namenda","company_name":"Inova Health Care Services","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, 5-hydroxytryptamine receptor 3A, Acetylcholinesterase","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"aducanumab-avwa","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"ADUHELM","generic_name":"ADUCANUMAB-AVWA","company_name":"BIOGEN INC","drug_phase":"marketed","molecular_target":"Amyloid beta A4 protein","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"acetylcarnitine","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levocarnitine Acetyl","generic_name":"ACETYLCARNITINE","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"Carnitine Analog","quality_score":null,"revenue":null,"mechanism":"Acetylcarnitine works by supporting the transport of fatty acids into mitochondria, where they can be used for energy production."},{"drug_id":"epicriptine","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Beta-Dihydroergocryptine","generic_name":"EPICRIPTINE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"epicriptine","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"memantine","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Namenda","generic_name":"MEMANTINE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Glutamate NMDA receptor; GRIN1/GRIN2A","drug_class":"N-methyl-D-aspartate Receptor Antagonist","quality_score":60,"revenue":null,"mechanism":"Namenda works by blocking the action of glutamate at the NMDA receptor, reducing excessive neural activity associated with Alzheimer's disease."},{"drug_id":"ebixa","indication_name":"Moderate to Severe Alzheimer's Type Dementia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ebixa","company_name":"Konkuk University Medical Center","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, 5-hydroxytryptamine receptor 3A, Acetylcholinesterase","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"lecanemab-irmb","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"LEQEMBI","generic_name":"LECANEMAB-IRMB","company_name":"EISAI INC","drug_phase":"marketed","molecular_target":"Amyloid beta A4 protein","drug_class":"Amyloid Beta-directed Antibody [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"florbetapir","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amyvid","generic_name":"FLORBETAPIR","company_name":"Avid Radiopharms Inc","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":45,"revenue":null,"mechanism":"Amyvid binds to beta-amyloid plaques in the brain, allowing for visualization of these plaques through PET imaging."},{"drug_id":"florbetapir","indication_name":"Alzheimer's disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amyvid","generic_name":"FLORBETAPIR","company_name":"Avid Radiopharms Inc","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":45,"revenue":null,"mechanism":"Amyvid binds to beta-amyloid plaques in the brain, allowing for visualization of these plaques through PET imaging."},{"drug_id":"donepezil-hydrochloride","indication_name":"Dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DONEPEZIL HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":28,"revenue":null,"mechanism":null},{"drug_id":"galantamine","indication_name":"Mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Razadyne","generic_name":"GALANTAMINE","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Inhibitor","quality_score":62,"revenue":null,"mechanism":"Razadyne works by blocking the enzyme that breaks down acetylcholine, allowing more of this neurotransmitter to be available in the brain."},{"drug_id":"galantamine-hydrobromide","indication_name":"Mild to moderate dementia of the Alzheimer's type","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"GALANTAMINE HYDROBROMIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":31,"revenue":null,"mechanism":null}],"pipeline":[{"drug_id":"valacyclovir","indication_name":"Alzheimer's Disease","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"VALACYCLOVIR","company_name":"","drug_phase":"marketed","molecular_target":"Viral DNA polymerase","drug_class":"Nucleoside analogue","quality_score":80,"revenue":null,"mechanism":"Valacyclovir is an antiviral drug that inhibits viral DNA polymerase to treat herpes simplex and varicella-zoster viruses."}],"offLabel":[],"totalMarketed":29,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT04321486","title":"Natural History and Patient Journey in Dementia: a Nationwide Linked Electronic Health Records Study of 5.6 Million Individuals.","phase":"","overall_status":"UNKNOWN","enrollment_count":4309481,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT05796037","title":"An Observational Study of Patients Living With Chronic Neurological Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1500000,"lead_sponsor_name":"Target PharmaSolutions, Inc.","has_results":false},{"nct_id":"NCT07205978","title":"Nut Consumption and Prevention of Non-communicable Diseases: A Global Individual Participant Data Meta-analysis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000000,"lead_sponsor_name":"Institut Investigacio Sanitaria Pere Virgili","has_results":false},{"nct_id":"NCT03943641","title":"Dementia Risk Prediction Model: Development and Validation","phase":"","overall_status":"COMPLETED","enrollment_count":400000,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT03631069","title":"Detecting Dementia in the Retina Using Optical Coherence Tomography","phase":"","overall_status":"UNKNOWN","enrollment_count":280000,"lead_sponsor_name":"Moorfields Eye Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT07093684","title":"Dementia and Kidney Disease: Epidemiological Approaches to Risk Factors and Treatment Strategies","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03638583","title":"Alzheimer Prevention Trials (APT) Webstudy","phase":"","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT02612688","title":"Pragmatic Trial of Video Education in Nursing Homes","phase":"NA","overall_status":"COMPLETED","enrollment_count":197692,"lead_sponsor_name":"Brown University","has_results":true},{"nct_id":"NCT05315895","title":"The Dampness Syndrome of Chinese Medicine Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Guangzhou University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT05817188","title":"Medication Repurposing to Stop Cognitive Decline in Dementia","phase":"","overall_status":"COMPLETED","enrollment_count":100000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04701177","title":"Digitally-enhanced, Decentralized, Multi-omics Observational Cohort","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100000,"lead_sponsor_name":"Greece 2021 Committee","has_results":false},{"nct_id":"NCT03653156","title":"China Cognition and Aging Study","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Capital Medical University","has_results":false},{"nct_id":"NCT03565809","title":"Quality of the Management of Diabetes in Elderly People With Dementia in France","phase":"","overall_status":"COMPLETED","enrollment_count":87816,"lead_sponsor_name":"University Hospital, Toulouse","has_results":false},{"nct_id":"NCT06877182","title":"Novel Neuroradiological Workflow for the Assisted DIAgnosis and Management of DEMentia with Artificial Intelligence","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":80000,"lead_sponsor_name":"IRCCS SYNLAB SDN","has_results":false},{"nct_id":"NCT06209515","title":"Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":61292,"lead_sponsor_name":"Kuopio University Hospital","has_results":false},{"nct_id":"NCT03621839","title":"New CSF Biomarkers for Alzheimer's Disease","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT03323502","title":"Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support","phase":"NA","overall_status":"COMPLETED","enrollment_count":47396,"lead_sponsor_name":"Indiana University","has_results":true},{"nct_id":"NCT05607732","title":"Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":45257,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT06033066","title":"Financial Incentives and Recruitment to the APT Webstudy","phase":"NA","overall_status":"COMPLETED","enrollment_count":44844,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT03657732","title":"The Chinese Familial Alzheimer's Network","phase":"","overall_status":"RECRUITING","enrollment_count":40000,"lead_sponsor_name":"Capital Medical University","has_results":false},{"nct_id":"NCT04571697","title":"A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":34647,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT05023564","title":"PUMCH Dementia Longitudinal Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06079203","title":"ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":19200,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT03945968","title":"The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.","phase":"","overall_status":"RECRUITING","enrollment_count":16000,"lead_sponsor_name":"Russian Federation of Anesthesiologists and Reanimatologists","has_results":false},{"nct_id":"NCT05147428","title":"A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":14442,"lead_sponsor_name":"University of Massachusetts, Worcester","has_results":true},{"nct_id":"NCT07177352","title":"Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":13000,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT06368115","title":"A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease: Implementation Phase 2","phase":"NA","overall_status":"COMPLETED","enrollment_count":11375,"lead_sponsor_name":"University of Massachusetts, Worcester","has_results":false},{"nct_id":"NCT04857060","title":"Palliative Care Educator","phase":"NA","overall_status":"COMPLETED","enrollment_count":11174,"lead_sponsor_name":"Tufts Medical Center","has_results":true},{"nct_id":"NCT04786561","title":"Depression, Anxiety and Social Relationships as Risk Factors for Dementia","phase":"","overall_status":"COMPLETED","enrollment_count":11000,"lead_sponsor_name":"Norwegian Centre for Ageing and Health","has_results":false},{"nct_id":"NCT01129596","title":"Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-","phase":"","overall_status":"COMPLETED","enrollment_count":10238,"lead_sponsor_name":"Eisai Co., Ltd.","has_results":false},{"nct_id":"NCT05010603","title":"Late Onset Alzheimer's Disease","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT06203106","title":"NYSCF Scientific Discovery Biobank","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"New York Stem Cell Foundation Research Institute","has_results":false},{"nct_id":"NCT04114994","title":"Longitudinal Cognitive Assessment by BoCA","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Alzheimer's Light LLC","has_results":false},{"nct_id":"NCT04466722","title":"The A-LIST WMM Insights Series","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"UsAgainstAlzheimer's","has_results":false},{"nct_id":"NCT03672448","title":"The China Longitudinal Aging Study of Cognitive Impairment","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Shanghai Mental Health Center","has_results":false},{"nct_id":"NCT05892952","title":"IONA Longitudinal Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Brain Health Scotland Life Sciences Ltd","has_results":false},{"nct_id":"NCT06719453","title":"Prevalence of Alzheimer's Disease Pathology in the Community","phase":"","overall_status":"COMPLETED","enrollment_count":9663,"lead_sponsor_name":"Helse Stavanger HF","has_results":false},{"nct_id":"NCT06058234","title":"Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study","phase":"","overall_status":"RECRUITING","enrollment_count":8680,"lead_sponsor_name":"Centers for Medicare and Medicaid Services/ Coverage and Analysis Group","has_results":false},{"nct_id":"NCT02162264","title":"Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice","phase":"","overall_status":"COMPLETED","enrollment_count":8662,"lead_sponsor_name":"Eisai Co., Ltd.","has_results":false},{"nct_id":"NCT03848312","title":"Preventing Alzheimer's With Cognitive Training","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":7600,"lead_sponsor_name":"University of South Florida","has_results":false},{"nct_id":"NCT04426539","title":"New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study","phase":"","overall_status":"COMPLETED","enrollment_count":6061,"lead_sponsor_name":"American College of Radiology","has_results":false},{"nct_id":"NCT04575337","title":"Study on Biomarkers for Early Diagnosis of Alzheimer's Disease","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Capital Medical University","has_results":false},{"nct_id":"NCT01322568","title":"Research on Aging Project in Iceland: Second Stage","phase":"","overall_status":"COMPLETED","enrollment_count":5764,"lead_sponsor_name":"National Institute on Aging (NIA)","has_results":false},{"nct_id":"NCT05231954","title":"Digital Detection of Dementia (D Cubed) Studies: D2","phase":"NA","overall_status":"COMPLETED","enrollment_count":5325,"lead_sponsor_name":"Indiana University","has_results":true},{"nct_id":"NCT04610944","title":"Changing Talk Online Training (CHATO) National Trial","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5043,"lead_sponsor_name":"University of Kansas Medical Center","has_results":false},{"nct_id":"NCT06322667","title":"A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Eisai Co., Ltd.","has_results":false},{"nct_id":"NCT03899298","title":"Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"R3 Stem Cell","has_results":false},{"nct_id":"NCT03592563","title":"CUHK Brain Health Longitudinal Study","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT04680013","title":"Genetic Studies in Familial Dementia","phase":"","overall_status":"COMPLETED","enrollment_count":4884,"lead_sponsor_name":"University of Miami","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}